Clinical Trials

FFP104-002

This is a phase II, double-blind, randomized, placebo-controlled, parallel group pilot study to investigate the safety and efficacy of FFP104 in the treatment of subjects with moderate to severely active Crohn’s Disease. The study will be conducted in the Netherlands and Belgium.

 

ClinicalTrials.gov Identifier: NCT02465944